Intertek helped in the development of second-generation breast cancer treatment by resolving the new drug's hold from the US Food and Drug Administration (FDA).
During clinical trials for this important treatment the FDA had concerns about the immune response in the study samples, with an extraordinarily high rate of positives. As a result, the trials were placed on hold. Intertek was able to independently test the data and help to assess and solve the issue.
Over the last 20 years, our network of pharmaceutical scientists and regulatory experts has worked for many of the world's largest and most innovative healthcare companies, and at every stage of development.
We provide contract pharmaceutical and biopharmaceutical laboratory services, supply chain audits and regulatory guidance, supporting drug development and production.
From early discovery through to late-stage clinical studies, our specialist teams provide essential knowledge, discretion, and capability where and when our clients need it.
Our experts work with you at every stage of development, providing consistently high quality and flexible services that enable better treatments around the world and marketplace advantages for healthcare companies.
Whether you have a complex issue to resolve, or already know exactly what you need, we'll help you make progress.
Just fill in your details below, and a subject matter expert will get in touch to see how we could help.
